Clincosm LogoSign in Get a demo

Recurrent Ovarian Carcinoma

Showing NaN - NaN of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma

Active, not recruiting
  • Recurrent Endometrial Endometrioid Adenocarcinoma
  • +4 more
  • Anchorage, Alaska
  • +584 more
Jan 28, 2023

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +14 more
  • Birmingham, Alabama
  • +399 more
Dec 30, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Active, not recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +5 more
  • Tucson, Arizona
  • +16 more
Oct 19, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +6 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 17, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +44 more
Jan 10, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
Has Results
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +17 more
  • Phoenix, Arizona
  • +162 more
Sep 28, 2021

Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Carcinoma Trial in Korea, Republic of, United States (Laboratory Biomarker

Completed
Has Results
  • Ovarian Clear Cell Adenocarcinoma
  • Recurrent Ovarian Carcinoma
  • Laboratory Biomarker Analysis
  • Sunitinib Malate
  • Birmingham, Alabama
  • +96 more
Feb 6, 2020

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Mobile, Alabama
  • +141 more
Jul 22, 2019

Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma Trial in United

Completed
  • Ovarian Clear Cell Cystadenocarcinoma
  • +7 more
  • Bevacizumab
  • +4 more
  • Aurora, Colorado
  • +12 more
Jul 19, 2019

Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,

Completed
Has Results
  • Adult Hepatocellular Carcinoma
  • +44 more
  • Scottsdale, Arizona
  • +60 more
Jan 24, 2019

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in United States (Paclitaxel

Completed
Has Results
  • Fallopian Tube Carcinoma
  • +2 more
  • Paclitaxel Albumin-Stabilized Nanoparticle Formulation
  • Aurora, Colorado
  • +19 more
Dec 14, 2017

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Rilotumumab
  • Burbank, California
  • +27 more
Aug 8, 2017

Collecting Tumor Samples From Patients With Gynecological Tumors

Completed
  • Borderline Ovarian Clear Cell Tumor
  • +85 more
  • Laboratory Biomarker Analysis
  • Fayetteville, Arkansas
  • +186 more
Oct 26, 2016

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Columbus

Completed
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Wild-type Reovirus
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 5, 2016